Project Grant R03AG088746
Award Date
8/1/25
Completion Date
7/31/27
Dollars Obligated
$156K
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Missouri, USA
Similar Awards
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), provides $376,310 to The Washington University in St. Louis to develop synthetic "chronogenetic" gene circuits in induced pluripotent stem cells. The goal is to engineer these cells to produce anti-cytokine biologic drugs on a circadian schedule, and incorporate them into tissue-engineered...
The Washington University Office of Sponsored Research Services Division was awarded a $311,000 Project Grant under the National Institute on Aging's Aging Research program (CFDA 93.866) to determine temporal links between changes in circadian rhythms, systemic inflammation, and delirium severity in older adults undergoing elective cardiac surgery. The research aims to establish the clinical relevance of molecular circadian rhythm disruptions during the perioperative period and shift delirium...
The U.S. National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $410,920 Project Grant under the Arthritis, Musculoskeletal and Skin Diseases Research (CFDA 93.846) program to The Washington University in St. Louis. The grant will fund a 5-year research project to investigate risk factors for end-stage glenohumeral (shoulder) osteoarthritis, with the objectives of determining associations between occupational exposures and shoulder arthroplasty risk,...
This Project Grant award from the National Institute on Aging (NIA), under the Aging Research program (CFDA 93.866), provides $688,634.00 in funding to The Hospital For Special Surgery Fund, Inc. (dba HSS Foundation) from December 1, 2024 to November 30, 2029. The award supports research to investigate the mechanisms by which the constitutive type-I interferon (IFN-I) response suppresses osteoblastogenesis and bone formation, especially in the context of inflammatory conditions like rheumatoid...
The National Institute on Aging (NIA) awarded a $639,997 Project Grant (CFDA 93.866 - Aging Research) to The Spaulding Rehabilitation Hospital Corporation to investigate how exercise regulates molecular circuitry in cartilage and the knee joint to promote cartilage integrity and joint health in the context of knee osteoarthritis. The 5-year project aims to provide mechanistic insights into how molecular cargoes in circulating extracellular vesicles impact osteoarthritic knee joint health in a...
The federal Project Grant award R56AG080294 in the amount of $440,000.00 was provided by the National Institute on Aging under their Aging Research program (CFDA 93.866). The grant supports research at the Beckman Research Institute of the City of Hope aimed at understanding the role of circadian clock regulation in the development of sarcopenic obesity, which is the loss of skeletal muscle mass and function with obesity in older adults. The research will employ transcriptomics and...
This federal Project Grant award from the National Institute on Aging's (NIA) Aging Research program (CFDA 93.866) provides $2,895,079 to Colorado State University to conduct research on the bidirectional relationship between neurodegenerative disease, sleep, and circadian clock disruption. The key objectives are to investigate how the spread of pathological protein aggregates impacts sleep and circadian rhythms, and how environmental circadian desynchronization can accelerate protein misfolding...
This Project Grant award from the National Institute on Aging (NIA), under CFDA 93.866 Aging Research, will provide $2,617,270 to Wake Forest University to conduct a 6-month remotely delivered group-mediated behavioral intervention targeting weight loss, increased physical activity, and reduced sitting time in older adults with chronic knee or hip osteoarthritic pain. The primary goal is to evaluate the intervention's impact on daily steps, pain interference, body weight, pain intensity, quality...
This $426,250 Project Grant awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) to the Regents of the University of Minnesota aims to develop an exosome-based therapy for the treatment of osteoarthritis (OA). The project will leverage the immunoregulatory mechanisms present during fetal development to identify multi-tissue organoid-derived exosomes with anti-inflammatory and chondrocyte proliferation potential. Key activities include in vitro studies using human PBMCs to...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), will support research to determine the role of the mechanosensitive protein PIEZO1 in joint homeostasis and osteoarthritis (OA) susceptibility. The $691,089 award, effective July 15, 2025 through June 30, 2030, will fund studies at the University of Utah to: 1) identify how mutations in PIEZO1...